[1]
2025. Evaluation of serum Cystatin C as a predictor of eGFR in type 2 diabetic patients with nephropathy. Journal of Shalamar Medical & Dental College - JSHMDC. 6, 1 (Jun. 2025), 03–08. DOI:https://doi.org/10.53685/jshmdc.v6i1.294.